Lis E - Search Results

1

Concurrent cetuximab, cisplatin, and concomitant boost radiotherapy for locoregionally advanced, squamous cell head and neck cancer: a pilot phase II study of a new combined-modality paradigm.

Pfister DG, Su YB, Kraus DH, Wolden SL, Lis E, Aliff TB, Zahalsky AJ, Lake S, Needle MN, Shaha AR, Shah JP, Zelefsky MJ. Pfister DG, et al. Among authors: lis e. J Clin Oncol. 2006 Mar 1;24(7):1072-8. doi: 10.1200/JCO.2004.00.1792. J Clin Oncol. 2006. PMID: 16505426 Clinical Trial.

2

Volumetric reduction of a choroid plexus carcinoma using preoperative chemotherapy.

Souweidane MM, Johnson JH Jr, Lis E. Souweidane MM, et al. Among authors: lis e. J Neurooncol. 1999 Jun;43(2):167-71. doi: 10.1023/a:1006229732653. J Neurooncol. 1999. PMID: 10533729 Review.

3

A phase II trial of bryostatin-1 in patients with metastatic or recurrent squamous cell carcinoma of the head and neck.

Pfister DG, McCaffrey J, Zahalsky AJ, Schwartz GK, Lis E, Gerald W, Huvos A, Shah J, Kraus D, Shaha A, Singh B, Wolden S, Zelefsky M, Palgi I. Pfister DG, et al. Among authors: lis e. Invest New Drugs. 2002 Feb;20(1):123-7. doi: 10.1023/a:1014449309165. Invest New Drugs. 2002. PMID: 12003188 Clinical Trial.

4

Primary leptomeningeal primitive neuroectodermal tumor.

Begemann M, Lyden D, Rosenblum MK, Lis E, Wolden S, Antunes NL, Dunkel IJ. Begemann M, et al. Among authors: lis e. J Neurooncol. 2003 Jul;63(3):299-303. doi: 10.1023/a:1024324700411. J Neurooncol. 2003. PMID: 12892237

5

Intensity-modulated radiotherapy for head-and-neck rhabdomyosarcoma.

Wolden SL, Wexler LH, Kraus DH, Laquaglia MP, Lis E, Meyers PA. Wolden SL, et al. Among authors: lis e. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1432-8. doi: 10.1016/j.ijrobp.2004.08.005. Int J Radiat Oncol Biol Phys. 2005. PMID: 15817347

6

Temozolomide plus thalidomide in patients with brain metastases from melanoma: a phase II study.

Hwu WJ, Lis E, Menell JH, Panageas KS, Lamb LA, Merrell J, Williams LJ, Krown SE, Chapman PB, Livingston PO, Wolchok JD, Houghton AN. Hwu WJ, et al. Among authors: lis e. Cancer. 2005 Jun 15;103(12):2590-7. doi: 10.1002/cncr.21081. Cancer. 2005. PMID: 15861414 Free article. Clinical Trial.

7

A phase II trial of thalidomide and cyclophosphamide in patients with recurrent or refractory pediatric malignancies.

Gilheeney SW, Lyden DC, Sgouros S, Antunes N, Gerald W, Kramer K, Lis E, Meyers P, Rosen N, Thaler HT, Trippett T, Wexler L, Dunkel IJ. Gilheeney SW, et al. Among authors: lis e. Pediatr Blood Cancer. 2007 Sep;49(3):261-5. doi: 10.1002/pbc.21045. Pediatr Blood Cancer. 2007. PMID: 16972243 Clinical Trial.

8

A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers.

Fury MG, Zahalsky A, Wong R, Venkatraman E, Lis E, Hann L, Aliff T, Gerald W, Fleisher M, Pfister DG. Fury MG, et al. Among authors: lis e. Invest New Drugs. 2007 Apr;25(2):165-72. doi: 10.1007/s10637-006-9011-x. Epub 2006 Sep 16. Invest New Drugs. 2007. PMID: 16983506 Clinical Trial.

9

Symptomatic Chiari type I malformation after radiation therapy in an infant: case report.

Hoffman CE, Lis E, Wolden SL, Souweidane MM. Hoffman CE, et al. Among authors: lis e. Neurosurgery. 2007 Apr;60(4):E782; discussion E782. doi: 10.1227/01.NEU.0000255357.09819.58. Neurosurgery. 2007. PMID: 17415188

10

Nonenhancing brain metastases.

Karimi S, Lis E, Gilani S, D'Ambrosio N, Holodny A. Karimi S, et al. Among authors: lis e. J Neuroimaging. 2011 Apr;21(2):184-7. doi: 10.1111/j.1552-6569.2009.00389.x. J Neuroimaging. 2011. PMID: 19490401

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

223 results

Search Page

Filters